ORIGINAL RESEARCH article
Front. Med.
Sec. Nuclear Medicine
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1630989
18F-FDG PET/CT in Xanthogranulomatous Cholecystitis with CA199 Elevation: Diagnostic Dilemmas and Differentiation Strategies
Provisionally accepted
- Jiangxi Provincial People's Hospital, Nanchang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: Xanthogranulomatous cholecystitis (XGC) is a rare and distinctive form of chronic cholecystitis, and it is rather challenging to differentiate it from the thick-walled type of gallbladder carcinoma. Considering that computed tomography (CT), magnetic resonance imaging (MRI), and 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) each exhibit unique features in the manifestation of XGC, this study aims to deepen the understanding of XGC and explore the roles of these imaging examinations, especially PET/CT, in the diagnosis and differential diagnosis of XGC. Methods: We retrospectively analyzed the radiological, clinical, and surgical pathological data of five patients with XGC treated at Jiangxi Provincial People's Hospital between January 2019 and January 2025. Results: All five patients with XGC were female, aged 49 to 84 years. Four patients were hospitalized for recurrent abdominal pain, while one presented with limb weakness. Carbohydrate antigen 19-9 (CA19-9) levels were elevated in three patients. Among the cases in this paper, one patient underwent contrast-enhanced MRI, two patients underwent contrast-enhanced CT, and all five patients underwent positron emission PET/CT examination. The results of the imaging examinations revealed that the gallbladder volume was enlarged in three cases and reduced in two cases. The gallbladder wall showed thickening to varying degrees (ranging approximately from 1.2 to 2.0 cm), with diffuse thickening observed in three cases and localized thickening in two cases. The enhancement pattern was characterized by progressive and sustained enhancement, and there was an increase in FDG uptake to different extents. Intramural nodules and gallstones were detected in three cases, and enlarged abdominal or retroperitoneal lymph nodes were found in two cases. The range of the maximum standardized uptake value (SUVmax) was between 7.5 and 19.8, and the median uptake value was 10.04 ± 5.75. Conclusion: In light of the insufficient diagnostic accuracy of FDG-PET/CT and CA 19-9 in distinguishing XGC from GBC, future efforts should prioritize the validation and adoption of advanced imaging techniques such as FLT-PET/CT. Pending these developments, radical cholecystectomy performed by experienced surgeons remains the recommended surgical strategy for suspected cases.
Keywords: Xanthogranulomatous cholecystitis, Gallbladder carcinoma, MRI, CT, 18F-FDG PET/CT
Received: 19 May 2025; Accepted: 05 Sep 2025.
Copyright: © 2025 Qi, Chen and Shao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Mingyan Shao, Jiangxi Provincial People's Hospital, Nanchang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.